PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26727197-0	2016	Long-term administration of tenofovir or emtricitabine to pregnant rats; effect on Abcb1a, Abcb1b and Abcg2 expression in the placenta and in maternal and fetal organs.	Tenofovir	28-37	ATP-binding cassette, subfamily B (MDR/TAP), member 1B	Rattus norvegicus	91-97	
26727197-2	2016	The aim of our study was to determine whether tenofovir or emtricitabine administered in long-term fashion affect expression of two widely described pharmacokinetic determinants, P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2), in maternal or fetal biological tissues.	Tenofovir	46-55	ATP-binding cassette, subfamily B (MDR/TAP), member 1B	Rattus norvegicus	179-193	
12124311-5	2002	As tenofovir DF is a substrate for P-glycoprotein (P-gp)-related efflux carriers in the Caco-2 model, the modulatory effect of the ester mixtures was studied on the functionality of P-gp using cyclosporin A (CsA) as a model substrate.	Tenofovir	3-15	ATP-binding cassette, subfamily B (MDR/TAP), member 1B	Rattus norvegicus	35-49	
12124311-5	2002	As tenofovir DF is a substrate for P-glycoprotein (P-gp)-related efflux carriers in the Caco-2 model, the modulatory effect of the ester mixtures was studied on the functionality of P-gp using cyclosporin A (CsA) as a model substrate.	Tenofovir	3-15	ATP-binding cassette, subfamily B (MDR/TAP), member 1B	Rattus norvegicus	51-55	
12124311-5	2002	As tenofovir DF is a substrate for P-glycoprotein (P-gp)-related efflux carriers in the Caco-2 model, the modulatory effect of the ester mixtures was studied on the functionality of P-gp using cyclosporin A (CsA) as a model substrate.	Tenofovir	3-15	ATP-binding cassette, subfamily B (MDR/TAP), member 1B	Rattus norvegicus	182-186